Sung-Hyeok Hong

Effect of natural and synthetic retinoids on the proliferation and differentiation of three canine melanoma cell lines.

A randomized controlled trial of octreotide pamoate long-acting release and carboplatin versus carboplatin alone in dogs with naturally occurring osteosarcoma: evaluation of insulin-like growth factor suppression and chemotherapy.

Effects of medetomidine-midazolam, acepromazine-butorphanol, and midazolam-butorphanol on induction dose of thiopental and propofol and on cardiopulmonary changes in dogs.

Effect of an adenoviral vector that expresses the canine p53 gene on cell growth of canine osteosarcoma and mammary adenocarcinoma cell lines.

Immobilization with ketamine HCl and tiletamine-zolazepam in cynomolgus monkeys.

Molecular cloning of the canine telomerase reverse transcriptase gene and its expression in neoplastic and non-neoplastic cells.

Establishment and characterization of four canine melanoma cell lines.

Establishment and characterization of eight feline mammary adenocarcinoma cell lines.

Application of a temporary palatal prosthesis in a puppy suffering from cleft palate.

Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases.

Idiopathic new bone formation in the femoral shafts of a cynomolgus monkey (Macaca fascicularis).

Murine osteosarcoma primary tumour growth and metastatic progression is maintained after marked suppression of serum insulin-like growth factor I.

Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis.

Modeling metastasis biology and therapy in real time in the mouse lung.

Assessment of experimental saccular aneurysm using selective angiography in common carotid artery of rabbits.

Dysregulation of ezrin phosphorylation prevents metastasis and alters cellular metabolism in osteosarcoma.

Apoptosis resistance and PKC signaling: distinguishing features of high and low metastatic cells.

Pharmacokinetic modeling optimizes inhibition of the 'undruggable' EWS-FLI1 transcription factor in Ewing Sarcoma.

A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft model.

High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases.

Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria Box.

YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model.

Ezrin Inhibition Up-regulates Stress Response Gene Expression.

Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model.

Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.